Thriving in Aesthetics Acne Management in the Aesthetic pati -

The live program has concluded.

If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.

Scroll back to top

Details

Overview
This comprehensive program is dedicated to discussing the best practices in skin care treatments for Acne Vulgaris in the aesthetic patient. This activity is intended to educate physicians and advanced practice providers via a didactic presentation on how to accurately assess common skin conditions that impact patients seeking aesthetic treatments. As well as how to treat, refer, or when to avoid treating those with skin conditions that require greater dermatological care will also be discussed.
Supported by an unrestricted education grant from Galderma.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Define the similarities and differences in philosophies and techniques of the various providers from unique academic, ethnic, cultural, and social backgrounds and how this may influence communication styles, products or techniques utilized.
- Define the similarities and differences in philosophies and techniques of the various providers from unique academic, ethnic, cultural, and social backgrounds and how this may influence communication styles, products or techniques utilized.
- Relate the nuances in training and practice types that may influence the techniques and treatments recommended and its acceptance in various patient populations.
- Recall the sensitivities in each culture, social economic backgrounds that may influence motivators or generate aversions from aesthetically inclined consumers when seeking out a specific provider for their treatments.
- Describe best practices for an aesthetic provider with a dermatological training background when treating a patient with Acne Vulgaris.
- Review and summarize a check list of considerations when evaluating a patient interested in cosmetic procedures who simultaneously has concerns regarding Acne vulgaris.
- Describe effective communication channels, styles and listening skills that are inherent to different providers, patients and consumer populations
- Identify, explain and manage the biases inherent in others as well as oneself as it relates to medical aesthetic information and treatment recommendations for Acne Vulgaris.
Accreditation
Jointly provided by Evolve Medical Education LLC (Evolve) and FabDay.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and FabDay. Evolve is accredited by the ACCME to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Faculty and Disclosures
Steven H Dayan, MD
Assistant Clinical Professor at the University of Illinois
Medical Director of DeNova Research

Sabrina Guillen Fabi, MD FAAD, FAACS
Volunteer Assistant Clinical Professor of Dermatology
University of California, San Diego
Cosmetic Laser Dermatology
A West Dermatology Company

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Steven H Dayan, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Galderma, Merz, Revance, Endo Pharmaceuticals, Croma, Inmode, Lumenis. Speaker's Bureau: Abbvie, Galderma, Merz, Endo Pharmaceuticals, Croma. Grant/Research Support: Abbvie, Galderma, Merz, Revance, Endo Pharmaceuticals. Stockholder: Revance Therapeutics
Sabrina Guillen Fabi, MD FAAD, FAACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Galderma, Merz, Revance, Endo Pharmaceuticals, NC8, Croma, Revelle, L'Oreal, Croma & Ortho Dermatologics. Speaker's Bureau: Abbvie, Galderma, Merz, Revance, Endo Pharmaceuticals, Ortho Dermatologics. Grant/Research Support: Abbvie, Galderma, Merz, Revance, Endo Pharmaceuticals, Croma, Exploramed, Ortho Dermatologics, Raziel. Stock Holder: Abbvie, Revance Therapeutics.
Kate Beleznay, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Galderma, Allergan, L'Oreal, J&J, P&G, Biossance, Avene, Neutrogena, Dove, Aveeno. Speaker’s Bureau: Galderma, Allergan, L'Oreal, J&J, P&G, Biossance, Avene, Neutrogena, Dove, Aveeno.

Sandra Lee Rebish, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Spokesperson: Sun Pharmaceuticals (winlevi)
Diane Berson, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Biofrontera, Sun, Ortho, Revance, Suneva, Almirall, Skinceuticals, LaRoche Posay. Shareholder: Regimen MD, TopMD
Joel Cohen, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Accure, Cutera, Sciton, Biofrontera. Research: Accure. Stockholder: Accure.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, FabDay, or Galderma.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 03/31/2023

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
0.25 credits
- Deepak Sambhara, MD
0.25 credits
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
0.25 credits
- Esther Lee Kim, MD
0.25 credits

Recommended

Title